Roivant Sciences Ltd

Common Name
Roivant Sciences
Country
United Kingdom
Sector
Healthcare
Industry
Biotechnology
Employees
908
Ticker
ROIV
Exchange
NASDAQ/NGS
Description
Roivant Sciences Ltd is a biopharmaceutical company focused on developing and commercializing innovative therapies through a unique model that emphasizes rapid and efficient drug delivery. As a platfo...

Financial Statements of Roivant Sciences

Below are the financial statements of Roivant Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD202520242023
Revenue
29.05a
32.71a
31.53a
Operating expenses
Cost of revenues
-0.91a
-1.6a
-3.03a
Research and development
-550.41a
-439.91a
-454.06a
Acquired in-process research and development
0a
-26.45a
-97.75a
General and administrative
-591.41a
-416.13a
-383.45a
Total operating expenses
-1,142.73a
-884.09a
-938.29a
Gain on sale of Telavant net assets
110.39a
5,348.41a
0a
(Loss) income from operations
-1,003.29a
4,497.03a
-906.76a
Change in fair value of investments
-55.19a
47.97a
20.82a
Change in fair value of liability instruments
-15.76a
46.84a
18.39a
Gain on deconsolidation of subsidiaries
-3.11a
-32.77a
-29.28a
Interest income
-258.38a
-146.43a
-32.18a
Other expense, net
10.72a
13.56a
0.49a
(Loss) income from continuing operations before income taxes
-681.59a
4,567.86a
-884.99a
Income tax expense
-48.17a
-21.5a
-4.08a
(Loss) income from continuing operations, net of tax
-729.76a
4,546.35a
-889.07a
Income (loss) from discontinued operations, net of tax
373.03a
-315.15a
-226.39a
Net (loss) income
-356.73a
4,231.21a
-1,115.46a
Net loss attributable to noncontrolling interests
-184.75a
-117.72a
-106.43a
Net (loss) income attributable to Roivant Sciences Ltd.
-171.98a
4,348.93a
-1,009.03a
Amounts attributable to Roivant Sciences Ltd.
(Loss) income from continuing operations, net of tax
-545.17a
4,662.7a
-784.35a
Income (loss) from discontinued operations, net of tax
373.19a
-313.78a
-224.68a
Net (loss) income attributable to Roivant Sciences Ltd.
-171.98a
4,348.93a
-1,009.03a

Verified Sources Behind Roivant Sciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Roivant Sciences’s data sources below and access millions more through our Disclosure Search.

a. Roivant Sciences's Annual Report 2024
Trace every data point back to Roivant Sciences’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?